Clinical trial
The influence of CYP3A5 and ABCB1 genotype on the pharmacokinetics of Prograf and Advagraf
The objectives of this study are
1) To determine the influence of CYP3A5 and ABCB1 genotypes on Advagraf pharmacokinetics
2) To compare the influence of these genotypes on the comparison between Prograf and Advagraf pharmacokinetics
Category | Value |
---|---|
Study start date | 2010-03-17 |